154 related articles for article (PubMed ID: 2416886)
1. Somatostatin-like immunoreactivity and substance-P-like immunoreactivity in the CSF of patients with senile dementia of Alzheimer type, multi-infarct syndrome and communicating hydrocephalus.
Cramer H; Schaudt D; Rissler K; Strubel D; Warter JM; Kuntzmann F
J Neurol; 1985; 232(6):346-51. PubMed ID: 2416886
[TBL] [Abstract][Full Text] [Related]
2. Immunoreactive substance P and somatostatin in the cerebrospinal fluid of senile parkinsonian patients.
Cramer H; Rissler K; Rösler N; Strubel D; Schaudt D; Kuntzmann F
Eur Neurol; 1989; 29(1):1-5. PubMed ID: 2468498
[TBL] [Abstract][Full Text] [Related]
3. Molecular size distribution of somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with degenerative brain disease.
Rissler K; Cramer H; Schaudt D; Strubel D; Gattaz WF
Neurosci Res; 1986 Feb; 3(3):213-25. PubMed ID: 2871533
[TBL] [Abstract][Full Text] [Related]
4. CSF somatostatin-like immunoreactivity in dementia.
Beal MF; Growdon JH; Mazurek MF; Martin JB
Neurology; 1986 Feb; 36(2):294-7. PubMed ID: 2868429
[TBL] [Abstract][Full Text] [Related]
5. Comparison of DSIP- (delta sleep-inducing peptide) and P-DSIP-like (phosphorylated) immunoreactivity in cerebrospinal fluid of patients with senile dementia of Alzheimer type, multi-infarct syndrome, communicating hydrocephalus and Parkinson's disease.
Ernst A; Cramer H; Strubel D; Kuntzmann F; Schoenenberger GA
J Neurol; 1987 Oct; 235(1):16-21. PubMed ID: 2448424
[TBL] [Abstract][Full Text] [Related]
6. Molecular forms of somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with senile dementia of the Alzheimer type.
Strittmatter M; Cramer H; Reuner C; Strubel D; Hamann G; Schimrigk K
Biol Psychiatry; 1997 Jun; 41(11):1124-30. PubMed ID: 9146823
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin-like immunoreactivity and acetylcholinesterase activities in cerebrospinal fluid of patients with Alzheimer disease and senile dementia of the Alzheimer type.
Gomez S; Davous P; Rondot P; Faivre-Bauman A; Valade D; Puymirat J
Psychoneuroendocrinology; 1986; 11(1):69-73. PubMed ID: 3517922
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid somatostatin in delirium.
Koponen H; Stenbäck U; Mattila E; Reinikainen K; Soininen H; Riekkinen PJ
Psychol Med; 1989 Aug; 19(3):605-9. PubMed ID: 2572025
[TBL] [Abstract][Full Text] [Related]
9. Cortical substance P-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type.
Crystal HA; Davies P
J Neurochem; 1982 Jun; 38(6):1781-4. PubMed ID: 6176686
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid levels of immunoreactive substance P and somatostatin in patients with multiple sclerosis and inflammatory CNS disease.
Rösler N; Reuner C; Geiger J; Rissler K; Cramer H
Peptides; 1990; 11(1):181-3. PubMed ID: 1692993
[TBL] [Abstract][Full Text] [Related]
11. Reduced cholinesterase activity and somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with dementia of the Alzheimer type.
Soininen HS; Jolkkonen JT; Reinikainen KJ; Halonen TO; Riekkinen PJ
J Neurol Sci; 1984 Feb; 63(2):167-72. PubMed ID: 6142929
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid immunoreactive substance P and somatostatin in neurological patients with peripheral and spinal cord disease.
Cramer H; Rösler N; Rissler K; Gagnieu MC; Renaud B
Neuropeptides; 1988 Oct; 12(3):119-24. PubMed ID: 2468107
[TBL] [Abstract][Full Text] [Related]
13. Neurochemical differences in the CSF between Binswanger's and Alzheimer's disease.
Strittmatter M; Hamann GF; Grauer MT; Cramer H; Schimrigk K
Dement Geriatr Cogn Disord; 1997; 8(1):34-42. PubMed ID: 8997550
[TBL] [Abstract][Full Text] [Related]
14. Substance P-like immunoreactivity and somatostatin-like immunoreactivity in the ventricular fluid of patients with chronic pain syndromes.
Jost S; Reuner C; Geiger J; Mohadjer M; Milios E; Cramer H
Eur Arch Psychiatry Clin Neurosci; 1991; 241(2):109-12. PubMed ID: 1834180
[TBL] [Abstract][Full Text] [Related]
15. Somatostatin-like immunoreactivity in lumbar cerebrospinal fluid from neurohistologically examined demented patients.
Francis PT; Bowen DM; Neary D; Palo J; Wikstrom J; Olney J
Neurobiol Aging; 1984; 5(3):183-6. PubMed ID: 6151122
[TBL] [Abstract][Full Text] [Related]
16. Low cerebrospinal fluid concentrations of peptide histidine valine and somatostatin-28 in Alzheimer's disease: altered processing of prepro-vasoactive intestinal peptide and prepro-somatostatin.
Yasuda M; Maeda K; Kakigi T; Minamitani N; Kawaguchi T; Tanaka C
Neuropeptides; 1995 Dec; 29(6):325-30. PubMed ID: 8837959
[TBL] [Abstract][Full Text] [Related]
17. Ventricular fluid neuropeptides in Parkinson's disease. I. Levels and distribution of somatostatin-like immunoreactivity.
Jost S; Reuner C; Mohadjer M; Mundinger F; Cramer H
Neuropeptides; 1990 Apr; 15(4):219-25. PubMed ID: 1979661
[TBL] [Abstract][Full Text] [Related]
18. Human cerebrospinal fluid somatostatin in neurologic disease.
Beal MF; Mazurek MF; Black PM; Martin JB
J Neurol Sci; 1985 Nov; 71(1):91-104. PubMed ID: 2868070
[TBL] [Abstract][Full Text] [Related]
19. Cortical somatostatin-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type.
Davies P; Terry RD
Neurobiol Aging; 1981; 2(1):9-14. PubMed ID: 6115327
[TBL] [Abstract][Full Text] [Related]
20. Somatostatin immunoreactivity in cortical and some subcortical regions in Alzheimer's disease.
Candy JM; Gascoigne AD; Biggins JA; Smith AI; Perry RH; Perry EK; McDermott JR; Edwardson JA
J Neurol Sci; 1985 Dec; 71(2-3):315-23. PubMed ID: 2868073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]